SCOPUS 정보 검색 플랫폼

The Lancet

Volumn 376, Issue 9740, 2010, Pages 495-496

After CAPRISA 004: Time to re-evaluate the HIV lexicon

(1) Cates Jr , Willard a

a FAMILY HEALTH INTERNATIONAL (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; PLACEBO; TENOFOVIR;

CLINICAL TRIAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; NOMENCLATURE; NOTE; PRIORITY JOURNAL; RISK REDUCTION; SEXUAL TRANSMISSION; VIRUS TRANSMISSION;

EID: 77956055380 PISSN: 01406736 EISSN: None Source Type: Journal
DOI: 10.1016/S0140-6736(10)61200-7 Document Type: Note

Times cited : (29)

References (7)

1
- 77955930318
- Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women
- on behalf of the CAPRISA 004 Trial Study Group J.A.
- Q Abdool Karim, SS Abdool Karim, JA Frolich on behalf of the CAPRISA 004 Trial Study Group Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women Science 2010 10.1126/science.1193748 published online July 19.
- (2010) Science
- Abdool, K.Q.¹ Abdool, S.K.S.² Frolich, J.A.³

2
- 48249121565
- Whither or wither microbicides?
- RM Grant, D Hamer, T Hope Whither or wither microbicides? Science 321 2008 532 534
- (2008) Science , vol.321 , pp. 532-534
- Grant, R.M.¹ Hamer, D.² Hope, T.³

3
- 77956043823
- Anon
- Anon Safety and effectiveness of tenofovir 1 gel, tenofovir disproxil fumarate, and emtricitabine/tenofovir disoproxil fumarate tablets in preventing HIV in women (VOICE, MTN-003) http://clinicaltrials.gov/ct2/show/NCT00705679 June 22, 2010 (accessed Aug 1, 2010).
- (2010) Safety and Effectiveness of Tenofovir 1 Gel, Tenofovir Disproxil Fumarate, and Emtricitabine/tenofovir Disoproxil Fumarate Tablets in Preventing HIV in Women (VOICE, MTN-003)

4
- 77956021318
- Anon
- Anon A pilot study of pre-exposure prophylaxis (PrEP) to evaluate safety, acceptability, and adherence in at-risk populations in Kenya, Africa (IAVI E001) http://clinicaltrials.gov/ct2/show/NCT00971230 Jan 11, 2010 (accessed Aug 1, 2010).
- (2010) A Pilot Study of Pre-exposure Prophylaxis (PrEP) to Evaluate Safety, Acceptability, and Adherence in At-risk Populations in Kenya, Africa (IAVI E001)

5
- 77956043607
- Anon
- Anon A pilot study of pre-exposure prophylaxis (PrEP) to evaluate safety, acceptability, and adherence in at-risk populations in Uganda, Africa (IAVI E002) http://clinicaltrials.gov/ct2/show/NCT00931346 April 19, 2010 (accessed Aug 1, 2010).
- (2010) A Pilot Study of Pre-exposure Prophylaxis (PrEP) to Evaluate Safety, Acceptability, and Adherence in At-risk Populations in Uganda, Africa (IAVI E002)

6
- 49349112505
- Biomedical interventions to prevent HIV infection: Evidence, challenges, and way forward
- NS Padian, A Buve, J Balkus, D Serwadda, W Cates Jr. Biomedical interventions to prevent HIV infection: evidence, challenges, and way forward Lancet 372 2008 585 599
- (2008) Lancet , vol.372 , pp. 585-599
- Padian, N.S.¹ Buve, A.² Balkus, J.³ Serwadda, D.⁴ Cates Jr., W.⁵

7
- 34247600748
- Narrative review: Antiretroviral therapy to prevent the sexual transmission of HIV-1
- MS Cohen, C Gay, ADM Kashuba, S Blower, L Paxton Narrative review: Antiretroviral therapy to prevent the sexual transmission of HIV-1 Ann Intern Med 146 2007 591 601
- (2007) Ann Intern Med , vol.146 , pp. 591-601
- Cohen, M.S.¹ Gay, C.² Kashuba, A.D.M.³ Blower, S.⁴ Paxton, L.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.